missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human ADPRHL1 (aa 21-88) Control Fragment Recombinant Protein
Description
Highest antigen sequence indentity to the following orthologs: Mouse (81%), Rat (81%). This recombinant protein control fragment may be used for blocking experiments. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
ADP-ribosylation is a reversible posttranslational modification used to regulate protein function. ADP-ribosyltransferases (see ART1; MIM 601625) transfer ADP-ribose from NAD+ to the target protein, and ADP-ribosylhydrolases, such as ADPRHL1, reverse the reaction (Glowacki et al., 2002 [PubMed 12070318]). [supplied by OMIM].
Specifications
Specifications
| Accession Number | Q8NDY3 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 113622 |
| Name | Human ADPRHL1 (aa 21-88) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | [Protein ADP-ribosylarginine] hydrolase-like protein 1; ADPRHL1; ADP-ribosylarginine hydrolase like 1; ADP-ribosyl-hydrolase; ADP-ribosylhydrolase 2; ADP-ribosylhydrolase like 1; Arh2; D330008N11Rik |
| Common Name | ADPRHL1 |
| Show More |